Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
New York Cannabis Market Integrity Is Now The Pressure Point
New York’s licensed cannabis market has surpassed $3 billion in legal sales, but market integrity is now the pressure point. Operators need to tighten seed to sale records, vendor documentation, product testing files, and supply chain controls as regulators push against illicit product entering licensed channels.
Minnesota Cannabis Bill Shows Market Rules Are Still Moving
Minnesota lawmakers advanced an omnibus cannabis bill that would replace the medical combination license with a new macrobusiness license, reduce canopy limits, create a ratio hemp infused product category, and give hemp businesses a path toward cannabis licensing. The bigger lesson is that market access, supply planning, and license strategy can change before a cannabis market fully matures.
RICO Class Action Raises The Stakes For Cannabis Product Claims And Litigation Risk
A new RICO class action against Cresco Labs, Green Thumb Industries, and Verano Holdings may signal a more aggressive phase of cannabis litigation. The bigger lesson for operators is that product claims, warnings, consumer disclosures, and insurance limits now deserve much tighter review.
D.C. Cannabis Lawsuit Dismissal Leaves Licensing Risk Unresolved
A federal lawsuit challenging D.C.’s cannabis licensing system was dismissed without prejudice, leaving key legal questions unresolved. The bigger lesson is that operators, landlords, lenders, and investors should still treat D.C. licensing and enforcement as live business risks.
Federal Hemp Ban Could Put CBD Access And CMS Pilot At Risk
A federal hemp ban scheduled for November 12, 2026 could affect more than intoxicating hemp products. The future 0.4 milligram total THC limit may pressure full spectrum CBD products and complicate a CMS pilot that allows certain eligible beneficiaries to receive hemp products through approved care models.
UK Medical Cannabis Access Is Legal On Paper But Still Hard In Practice
The UK legalized medical cannabis in 2018, but real patient access remains extremely limited through the NHS. The bigger lesson is that legal reform alone does not create a functioning market when clinician confidence, affordability, and prescribing infrastructure are still weak.
Auxly’s Q1 Growth Shows How Taxes Still Squeeze Cannabis Operators
Auxly reported higher Q1 2026 revenue driven by flower and pre roll sales, but the bigger business lesson is tax pressure. The company incurred just under $20 million in excise taxes on $59.7 million in cannabis product sales, showing why operators need to track product mix, pricing, and cash flow beyond top line growth.
Georgia Medical Cannabis Expansion Creates A More Serious Limited License Market
Georgia’s Senate Bill 220 expands the state’s medical cannabis program by allowing vaping, adding qualifying conditions, and replacing the former THC cap with a possession limit. The bigger lesson is that Georgia is creating a more serious medical market while keeping a tightly controlled limited license structure.
Fluent’s New York Closure Shows Growth Does Not Always Mean Profitability
Fluent owned Etain is closing its Chestertown cultivation and packaging facility ahead of Vireo Growth’s planned acquisition of Fluent. The bigger lesson is that New York cannabis may be growing on paper, but operators still need cost discipline, cash flow control, and a clear plan for facilities that no longer fit the strategy.
Cannabis License Decline Shows The Easy Expansion Era Is Over
Active U.S. cannabis business licenses fell to 36,169 in the first quarter of 2026, extending a seven quarter decline. The bigger lesson for operators is that market access, renewals, capital planning, and survival margins now deserve more attention than expansion headlines.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

Trulieve and Cronos have each gained roughly 27 percent in 2026 while reporting stronger operating results. The broader signal is that public market attention is increasingly rewarding cash generation, improving margins, liquidity, and measurable revenue growth.